WallStSmart
SPRC

Scisparc Ltd

NASDAQ: SPRC · HEALTHCARE · BIOTECHNOLOGY

$8.77
-2.88% today

Updated 2026-04-30

Market cap
$4.72M
P/E ratio
0.00
P/S ratio
3.61x
EPS (TTM)
$3,156.52
Dividend yield
52W range
$3 – $95
Volume
0.5M

WallStSmart proprietary scores

28
out of 100
Grade: F
Strong Sell
Investment rating
4.0
Growth
C
4.5
Quality
C
2.5
Profitability
F
5.0
Valuation
C+
2/9
Piotroski F-Score
Weak
-7.9
Altman Z-Score
Distress
Industry rank
View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target
$—
12-Month target
$21,464.34
+244647.32%
Intrinsic (DCF)
Margin of safety

Price chart

X-Ray snapshot

Strengths
+ Debt/equity -3.14x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Altman Z -7.88 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-1.86M
- Revenue declining -45.10% QoQ

Key financials

Revenue Net Income Free Cash Flow
Metric2021202220232024TTM
Revenue$1.07M$1.35M$2.88M$1.31M$1.31M
Net income$-5.80M$-2.59M$-5.12M$-6.28M$-9.33M
EPS$3,156.52
Free cash flow$-5.10M$-12.79M$-5.89M$-5.10M$-1.86M
Profit margin-542.66%-192.43%-177.91%-481.16%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
SPRC$4.72M284.02.55.04.5Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Scisparc Ltd trades at $8.77. Our Smart Value Score of 28/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -7.88, it sits in the distress. TTM revenue stands at $1.31M.

Frequently asked questions

What is Scisparc Ltd's stock price?
Scisparc Ltd (SPRC) trades at $8.77.
Is Scisparc Ltd overvalued?
Smart Value Score 28/100 (Grade F, Strong Sell).
What is the price target of Scisparc Ltd (SPRC)?
The analyst target price is $—, representing NaN% downside from the current price of $8.77.
What is Scisparc Ltd's revenue?
TTM revenue is $1.31M.
Piotroski F-Score?
2/9 — weak financial health.
Altman Z-Score?
-7.88 — distress.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio3.61x
ROE-1,281.00%
Beta1.33
50D MA$4.65
200D MA$22.82
Shares out0.00B
Float0.00B
Short ratio
Avg volume0.5M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years